Trial Puts Spotlight on Merck

Courtesy NYT > Business  Wed, 05/13/2009 - 20:11

A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity.


 

Related items

US high court to decide on allowing Vioxx suits
The U.S. Supreme Court will decide whether shareholders can sue Merck & Co. over whether the drugmaker provided adequate information about the risks of its former blockbuster painkiller Vioxx...

Novartis to pay $99 M to settle overtime lawsuit
A U.S. division of Swiss drugmaker Novartis AG says it will pay $99 million to settle a class-action lawsuit about overtime pay for U.S. sales representatives.

Women charging sex bias have until Oct. 28 to sue...
Women who were part of a massive class-action lawsuit against Wal-Mart Stores Inc.

Samsung SCX-4200 3-in-1 True Multifunction Printer
The SCX-4200 Digital Productivity Center is a low cost black and white laser printer, delivering 3 in 1 true multifunction performance with professional laser output.Keep your valuable real...

Canon 13 x 19 Inch Semi Gloss Photo Paper Plus, 20...
270 gsm Basis Weight / 10.5 mil Thickness / 92 ISO Brightness / Semi-Gloss Surface Finish and Vibrant Color / Have the look and feel of a traditional photo


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com